Agreed. Any entrepreneur would be trying to get a return on the investment already made. They have viable product. In the cost reduction move to lower the burn rate, they cut sales force. Pharma sales forces are expensive but you need marketing and sales to recoup investment. Convention traffic would have been greater if there were more product awareness.
They will be successful long term. It is just taking longer than it should and relying too much on outside capital.
I hope the next CEO will have a track record of growing small pharma or device companies.
News 
Market Data 
Discover 
